The attitudes of religious, environmental, and science policy leaders toward biotechnology.

Recombinant DNA technical bulletin Pub Date : 1985-12-01
J D Miller
{"title":"The attitudes of religious, environmental, and science policy leaders toward biotechnology.","authors":"J D Miller","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Biotechnology is an increasingly visible and important item on the national science policy agenda. With growing corporate and governmental funding, basic research in recombinant DNA and related technologies is expanding rapidly. In a parallel and related process, new agricultural, medical, and other applications are being developed and a growing list of genetically-engineered products is ready for field testing and market distribution. In the months and years ahead, the flow of genetically-engineered products into the marketplace and the media coverage related to those new products will increase the public's awareness of biotechnology. In addition, it is possible that some public policy debate will occur over the issue of field testing new genetically-engineered materials. Media coverage of this type of controversy will also heighten awareness and influence the aggregate level of public awareness of biotechnology. The prospect of a public debate or controversy over any biotechnology issue illustrates a fundamental problem in the formulation of science policy within a democratic political system. The processes and techniques involved in genetic engineering and complex and require some level of scientific background knowledge. A 1979 study found that only seven per cent of American adults met a minimal definition of scientific literacy. It is clear that the current levels of public awareness and knowledge about biotechnology will not allow a public policy debate similar to those associated with controversies involving Social Security or gasoline prices. How, then, does a democratic society establish public policies on advanced technical issues like biotechnology? This report will outline a model of policy formulation for specialized issues and describe the results of a national study of relevant policy leaders concerning biotechnology. To understand the formulation of public policy toward biotechnology, it is necessary to focus on the role of the policy leaders in a stratified model. In general, when there is agreement on a given policy between the decision-makers and the policy leaders, the policy is implemented and there is no wider involvement in the policy formulation process. A large number of science and technology policy issues have been handled in this manner in the decades since the Second World War and it is likely that most science policy matters will continue to be resolved directly between policy leaders and decision-makers. Looking at the general science policy formulation process, it is clear that policy leaders are an important component.(ABSTRACT TRUNCATED AT 400 WORDS)</p>","PeriodicalId":77777,"journal":{"name":"Recombinant DNA technical bulletin","volume":"8 4","pages":"141-64"},"PeriodicalIF":0.0000,"publicationDate":"1985-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Recombinant DNA technical bulletin","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Biotechnology is an increasingly visible and important item on the national science policy agenda. With growing corporate and governmental funding, basic research in recombinant DNA and related technologies is expanding rapidly. In a parallel and related process, new agricultural, medical, and other applications are being developed and a growing list of genetically-engineered products is ready for field testing and market distribution. In the months and years ahead, the flow of genetically-engineered products into the marketplace and the media coverage related to those new products will increase the public's awareness of biotechnology. In addition, it is possible that some public policy debate will occur over the issue of field testing new genetically-engineered materials. Media coverage of this type of controversy will also heighten awareness and influence the aggregate level of public awareness of biotechnology. The prospect of a public debate or controversy over any biotechnology issue illustrates a fundamental problem in the formulation of science policy within a democratic political system. The processes and techniques involved in genetic engineering and complex and require some level of scientific background knowledge. A 1979 study found that only seven per cent of American adults met a minimal definition of scientific literacy. It is clear that the current levels of public awareness and knowledge about biotechnology will not allow a public policy debate similar to those associated with controversies involving Social Security or gasoline prices. How, then, does a democratic society establish public policies on advanced technical issues like biotechnology? This report will outline a model of policy formulation for specialized issues and describe the results of a national study of relevant policy leaders concerning biotechnology. To understand the formulation of public policy toward biotechnology, it is necessary to focus on the role of the policy leaders in a stratified model. In general, when there is agreement on a given policy between the decision-makers and the policy leaders, the policy is implemented and there is no wider involvement in the policy formulation process. A large number of science and technology policy issues have been handled in this manner in the decades since the Second World War and it is likely that most science policy matters will continue to be resolved directly between policy leaders and decision-makers. Looking at the general science policy formulation process, it is clear that policy leaders are an important component.(ABSTRACT TRUNCATED AT 400 WORDS)

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
宗教、环境和科学政策领袖对生物技术的态度。
生物技术是国家科学政策议程上一个日益明显和重要的项目。随着企业和政府资金的增加,重组DNA和相关技术的基础研究正在迅速扩大。在一个平行和相关的过程中,正在开发新的农业、医疗和其他应用,并且越来越多的基因工程产品已准备好进行实地测试和市场分销。在未来的几个月和几年里,基因工程产品流入市场以及与这些新产品有关的媒体报道将增加公众对生物技术的认识。此外,在实地测试新的基因工程材料的问题上,可能会出现一些公共政策辩论。媒体对这类争议的报道也将提高公众对生物技术的认识,并影响公众对生物技术的总体认识水平。关于任何生物技术问题的公开辩论或争论的前景说明了在民主政治体制内制定科学政策的一个基本问题。基因工程涉及的过程和技术复杂,需要一定程度的科学背景知识。1979年的一项研究发现,只有7%的美国成年人达到了科学素养的最低标准。很明显,目前公众对生物技术的认识和知识水平将不允许进行类似于涉及社会保障或汽油价格的争议的公共政策辩论。那么,一个民主社会如何就生物技术等先进技术问题制定公共政策呢?本报告将概述一个专门问题的政策制定模式,并描述一项关于生物技术的有关政策领导人的国家研究的结果。为了理解生物技术公共政策的制定,有必要关注政策领导者在分层模型中的作用。一般来说,当决策者和政策领导人之间就某项政策达成协议时,政策就会得到实施,而不会更广泛地参与政策制定过程。自第二次世界大战以来的几十年里,大量的科学和技术政策问题都是以这种方式处理的,而且很可能大多数科学政策问题将继续在政策领导人和决策者之间直接解决。纵观一般的科学政策制定过程,很明显,政策领导人是一个重要的组成部分。(摘要删节为400字)
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Department of Health and Human Services, National Institutes of Health. Recombinant DNA research: proposed actions under the guidelines. Department of Health and Human Services, Public Health Service, National Institutes of Health. Human Gene Therapy Subcommittee. Minutes of Meeting, June 1, 1990. Recombinant DNA Advisory Committee regional hearings, 1990. Written statements. Department of Health and Human Services. Recombinant DNA research; proposed actions under the guidelines. Field testing genetically modified organisms: framework for decisions. National Research Council executive summary.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1